primary%20angle-closure%20glaucoma
PRIMARY ANGLE-CLOSURE GLAUCOMA
Primary angle-closure is the synechial or appositional closure of the anterior chamber angle secondary to multiple mechanisms resulting in raised intraocular pressure and structural changes in the eyes.
Iridotrabecular contact is the hallmark of primary angle-closure  and the most commonly identified sign which indicates that treatment is required.
It is defined by at least 180 degrees of iridotrabecular contact together with an elevated intraocular pressure or peripheral anterior synechiae or btoh
Primary angle-closure glaucoma is the presence of glaucomatous optic neuropathy.

Primary Angle-Closure Glaucoma Drug Information

Drug Information

Indication: Decreased IOP in adult patients w/ open-angle glaucoma or ocular HTN for whom monotherapy provides insufficien...

Indication: Elevated IOP in ocular HTN or open-angle glaucoma.

Indication: Chronic open-angle glaucoma, ocular HTN.

Indication: Elevated IOP in patients w/ ocular HTN & open-angle glaucoma when concomitant therapy is appropriate.

Indication: Decrease of IOP in adults w/ open-angle glaucoma or ocular HTN who are insufficiently responsive to topical &b...

Indication: Elevated IOP in patients w/ ocular HTN or open-angle glaucoma.

Indication: Decrease of elevated IOP in adults w/ ocular HTN or open-angle glaucoma.

Indication: Reduction of elevated IOP in patients w/ open-angle glaucoma, chronic angle closure glaucoma & ocular HTN;...

Simbrinza
brimonidine tartrate + brinzolamide

Indication: Decrease of elevated IOP in adults w/ open-angle glaucoma or ocular HTN for whom monotherapy provides insuffic...

Indication: Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.

1  /  3
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.